Grindr Inc. (GRND)

Achilles Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	363.23	344.64	259.69	195.02	145.83	104.46
Revenue Growth (YoY)	30.08%	32.71%	33.16%	33.73%	39.60%	-3.90%
Cost of Revenue	92.5	87.58	67.46	51.28	37.36	31.42
Gross Profit	270.73	257.06	192.23	143.74	108.48	73.04
Selling, General & Admin	117.18	113.55	78.08	67.07	24.85	31.25
Research & Development	37.3	32.75	19.97	17.9	10.91	14.41
Operating Expenses	170.75	163.21	123.78	121.81	78.63	72.71
Operating Income	99.98	93.85	68.45	21.93	29.84	0.33
Interest Expense	-22.31	-25.62	-46.01	-19.53	-17.6	-11.4
Interest & Investment Income	-	-	-	-	-	0.28
Other Non Operating Income (Expenses)	-156.42	-185.27	-49.6	18.34	-0.82	-3.62
EBT Excluding Unusual Items	-78.75	-117.04	-27.16	20.73	11.42	-14.41
Merger & Restructuring Charges	-	-	-	-6.5	-4.35	-
Asset Writedown	-	-	-1.31	-0.67	-0.37	-1.24
Legal Settlements	-1.19	-1.19	-2.34	-1.72	-1.91	-
Other Unusual Items	-0.06	-0.06	-20.94	-11.85	1.51	-
Pretax Income	-79.99	-118.29	-51.75	-0.01	6.3	-15.65
Income Tax Expense	14.58	12.71	4.02	-0.86	1.24	-2.57
Net Income	-94.58	-131	-55.77	0.85	5.06	-13.07
Net Income to Common	-94.58	-131	-55.77	0.85	5.06	-13.07
Net Income Growth	-	-	-	-83.17%	-	-
Shares Outstanding (Basic)	179	176	174	158	153	102
Shares Outstanding (Diluted)	179	176	174	159	153	102
Shares Change (YoY)	2.74%	0.98%	9.43%	4.12%	50.33%	1.14%
EPS (Basic)	-0.53	-0.74	-0.32	0.01	0.03	-0.13
EPS (Diluted)	-0.58	-0.74	-0.32	0.01	0.03	-0.13
EPS Growth	-	-	-	-82.01%	-	-
Free Cash Flow	97.43	94.01	35.64	50.21	34.16	25.59
Free Cash Flow Per Share	0.54	0.54	0.20	0.32	0.22	0.25
Gross Margin	74.53%	74.59%	74.02%	73.70%	74.38%	69.92%
Operating Margin	27.53%	27.23%	26.36%	11.24%	20.46%	0.32%
Profit Margin	-26.04%	-38.01%	-21.48%	0.44%	3.47%	-12.51%
Free Cash Flow Margin	26.82%	27.28%	13.72%	25.75%	23.43%	24.50%
EBITDA	112.66	107.17	91.64	57.87	72.65	27.01
EBITDA Margin	31.02%	31.09%	35.29%	29.68%	49.81%	25.86%
D&A For EBITDA	12.68	13.32	23.18	35.95	42.8	26.68
EBIT	99.98	93.85	68.45	21.93	29.84	0.33
EBIT Margin	27.53%	27.23%	26.36%	11.24%	20.46%	0.32%
Effective Tax Rate	-	-	-	-	19.62%	-
Advertising Expenses	-	8.22	2.38	3.01	1.29	3.32

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q